Two cases of atrial flutter with fetal hydrops: successful fetal drug therapy

We describe two cases of fetal atrial flutter associated with severe fetal hydrops which were unresponsive to digoxin but were successfully treated with flecainide acetate. Two cases of fetal atrial flutter were identified in fetuses with severe fetal hydrops on 3rd trimester ultrasonogram(28 weeks&...

Full description

Saved in:
Bibliographic Details
Published inJournal of Korean medical science Vol. 13; no. 6; pp. 676 - 679
Main Authors Won, H S, Lee, I S, Yoo, H K, Yoo, S J, Ko, J K, Lee, P R, Kim, A, Mok, J E
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Academy of Medical Sciences 01.12.1998
Subjects
Adult
Anti-Arrhythmia Agents - therapeutic use
Atrial Flutter - drug therapy
Digoxin - therapeutic use
Female
Flecainide - therapeutic use
Humans
Hydrops Fetalis - drug therapy
Pregnancy
Online AccessGet full text

Cover

More Information
Summary:We describe two cases of fetal atrial flutter associated with severe fetal hydrops which were unresponsive to digoxin but were successfully treated with flecainide acetate. Two cases of fetal atrial flutter were identified in fetuses with severe fetal hydrops on 3rd trimester ultrasonogram(28 weeks' gestation and 30 weeks' gestation). Following failed digoxin monotherapy, flecainide acetate was added to digoxin. On the 7th day and 13th day after combined therapy, fetal heart rate converted to normal sinus rhythm without recurrence. Our cases showed that the combined therapy of digoxin and flecainide acetate can effectively treat fetal atrial flutter associated with fetal hydrops unresponsive to digoxin monotherapy.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1011-8934
1598-6357
DOI:10.3346/jkms.1998.13.6.676